Azizi Fereidoun, Mehran Ladan, Hosseinpanah Farhad, Delshad Hossein, Amouzegar Atieh
a Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences , Tehran , Iran.
b Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences , Tehran , Iran.
Endocr Res. 2018 May;43(2):124-140. doi: 10.1080/07435800.2018.1424720. Epub 2018 Jan 10.
Secondary and tertiary preventions are concerned with the recognition of the disease process in a very early stage and delay in progression to complete disease and minimization of complications and the impact of illness.
All articles related to secondary and tertiary prevention of thyroid diseases were reviewed. Using related key words, articles published between 2001 and 2015 were evaluated, categorized, and analyzed.
In secondary prevention, congenital hypothyroidism and subclinical hypo and hyperthyroidism are equally important. Routine screening of patients with multinodular goiter by either ultrasonography or calcitonin is a controversial issue, while calcitonin assessments in medullary cancer and RET in family members are recommended. Screening of thyroid disease in pregnancy is limited to those with risk factors. Views regarding the importance of thyroid autoimmunity in secondary prevention are also presented. In tertiary prevention, prescribing excessive doses of levothyroxine, in the elderly in particular and appropriate care of all patients to avoid progression and complications are the key issues.
Optimization of management of thyroid diseases requires timely screening, prevention of progression to more sever disease, optimal medical care, and avoidance of iatrogenic conditions.
二级预防和三级预防旨在极早期识别疾病进程,延缓疾病进展至完全发病,并将并发症及疾病影响降至最低。
对所有与甲状腺疾病二级和三级预防相关的文章进行综述。使用相关关键词,对2001年至2015年间发表的文章进行评估、分类和分析。
在二级预防中,先天性甲状腺功能减退症以及亚临床甲状腺功能减退和亢进同样重要。通过超声检查或降钙素对多结节性甲状腺肿患者进行常规筛查存在争议,而推荐对髓样癌患者进行降钙素评估以及对家庭成员进行RET检测。孕期甲状腺疾病筛查仅限于有危险因素的人群。文中还阐述了关于甲状腺自身免疫在二级预防中的重要性的观点。在三级预防中,尤其要避免给老年人开具过量左甲状腺素,并对所有患者进行适当护理以避免疾病进展和并发症,这是关键问题。
优化甲状腺疾病管理需要及时筛查、预防疾病进展至更严重阶段、提供最佳医疗护理并避免医源性情况。